Association of CYP1A1FNx012 polymorphisms with breast cancer risk : AAA case control study

Indian Journal of Medical Sciences

Volumn 63, Issue 1, 2009, Pages 13-20

  Surekha, D ^a   Sailaja, K ^a   Rao, D ^a   Padma, T ^a   Raghunadharao, D ^b   Vishnupriya, S ^a  

^a OSMANIA UNIVERSITY   (India)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Association; Breast cancer; CYP1A1FNx012; Polymorphisms; Receptor status

Indexed keywords

CYTOCHROME P450 1A1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; VALINE; CYTOCHROME P450 1A2;

ALLELE; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREMENOPAUSE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; RISK ASSESSMENT;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK ASSESSMENT;

EID: 64749085744     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.49077     Document Type: Article

References (30)

1. Kawajiri K, Watanabe J, Gotoh O, Tagashira Y, Sogawa K, Fujii-Kuriyama Y. Structure and drug inducibility of the human cytochrome P-450c gene. Eur J Biochem 1986;159:219-25.
2. Smith CA, Smith G, Wolf CR. Genetic polymorphisms in xenobiotic metabolism. Eur J Cancer Am 1994;30:1921-35.
3. Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 1998;19: 291-8.
4. McKay JA, Murray GI, Ah-See AK, Greenlee WF, Marcus CB, Burke MD, et al. Differential expression of CYP1A1 and CYP1B1 in human breast cancer. Biochem Soc Trans 1996;24:327S.
5. Huang Z, Fasco MJ, Figge HL, Keyomarsi K, Kaminsky LS. Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab Dispos 1996;24:899-905.
6. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000;9:3-28.
7. Firozi PF, Bondy ML, Sahin AA, Chang P, Lukmanji F, Singletary ES, et al. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. Carcinogenesis 2002;23:301-6.
8. Suzuki K, Matsui H, Nakazato H, Koike HI, Okugi H, Hasumi. M, et al. Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: A case-control study. Cancer Lett 2003;195:177-83.
9. Aktas D, Guney I, Alikasifoglu M, Yuce K, Tuncbilek E, Ayhan A. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm. Gynecol Oncol 2002;86:124-8.
10. Moysich B, Shields G, Freudenheim L, Schisterman F, Vena E, Kostynaik, et al. Polychlorinated Biphenyls, Cytochrome P4501A1 polymorphism and postmenopausal breast cancer risk. Cancer Epidemiol, Biomarkers Prev 1999;8:41-4.
11. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 2004;279: 23847-50.
12. Singh N, Mitra AK, Garg VK, Agarwal A, Sharma M, Chaturvedi R, et al. Association of CYP1A1 polymorphisms with breast cancer in North Indian women. Oncol Res Featuring Preclin Clin Cancer Ther 2007;16:587-97.
13. Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singth MP. A study on the association of Cytochrome-P 4501A1 polymorphism and breast cancer risk in north Indian women. Breast cancer Res Treat 2007;102:73-81.
14. Shin A, Kang D, Choi JY, Lee KM, Park SK, Noh DY, et al. Cytochrome P450 1A1 (CYP1A1) polymorphisms and breast cancer risk in Korean women. Exp Mole Med 2007;39:361-6.
15. Nuremberg J., Lahari DK Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood RFLP studies. Nucleic Acid Res 1991;19:5444.
16. Wang LD, Zheng S, Liu B, Xiang J, Li YJ, Li JX. CYP1A1, GSTs and MEH polymorphisms and susceptibility to esophageal carcinoma: Study of population from a high-incidence area in north China. World J Gastroenterol 2003;9:1394-7.
17. Breinholt VM, Offord EA, Brouwr C, Nielsen SE, Brosen K, Friedberg TH. In vitro investigation of cytochrome P450- mediated metabolism of dietary avanoids. Food Chem Toxicol 2002;40:609-16.
18. Smith G, Stanley LA, Sim E, Strange RC, Wolf CR. Metabolic polymorphisms and cancer susceptibility, Cancer surveys Vol.254: genetics and cancer: a second look 27-65,1995.
19. Norback DH, Weltman RH. Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ Health Perspect 1985;60:97-105.
20. Kimbrough RD. Human health effects of polychlorinated biphenyls (PCBs) and polybromated biphenyls (PBBs). Annu Rev Pharmacal Toxicol 1987;27:87-111.
21. Safe S. Polychlorinated biphenyls (PCBs): Mutagenicity and carcinogenicity.Mutat.Res 1989;224:79-88.
22. Murata M, Watanabe M, Yamanaka Y, Kubota Y, Ito H, Nagao M, et al. Genetic polymorphisms in cytochrome P450 (CYP) 1A1,CYP1A2, CYP2E1, gluthathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostrate cancer in the Japanese population. Cancer Lett 2001;165: 171-7.
23. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, et al. Cytochrome P4501A1 and gluthathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 1995;55:3483-5.
24. Vineis P, Vsglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper ML et al. CYP1A1 T3801c polymorphism and lung cancer: Pooled analysis of 2,451 cases and 3358 controls. Int J Cancer 2003;104:650-7.
25. Ishibe N, Hankinson SE, Colditz GA, Spiegelman D, Willett WC, Speizer FE, et al. Cigarette smoking, cytochrome P450 1A1 polymorphisms and breast cancer risk in the Nurses' Health Study. Cancer Res 1998;58:667-71.
26. Huang CS, Shen CY, Hsu SM, Chern HD. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. Br J Cancer 1999;80:1838-43.
27. Miyoshi Y, Noguchi S. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women. Biomed Pharmacother 2003;57:471-81.
28. Androutsopoulos V, Arroo RR, Hall JF, Surichan S, Potter GA. Antiproliferative and cytostatic effects of the natural product euparation on MDA-MB486 human breast cancer cells due to CYP1 mediated metabilosm. Breast Cancer Res 2008;10:R39.
29. Han W, Kang D, Park IA, Kim SW, Bae JY, Chung KW, et al. Association between breast cancer susceptibility gene polymorphism and clinicopathological features. Clin Cancer Res 2004;10:124-30.
30. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, et al. Molecular origin of cancer: Catechol estrogen-3, 4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 1997;94:10937-42.